{
  "variants": [
    {
      "variant": {
        "gene": "SNCA",
        "protein_change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence": {
        "evidence_aim": "Pathogenic",
        "steps": [
          {
            "step": "1",
            "description": "Defined disease mechanism: α-synuclein aggregation is linked to Parkinson's disease (PD).",
            "judgment": "Yes"
          },
          {
            "step": "2",
            "description": "Assays (fluorescence analysis, NMR chemical shift analysis) are relevant to the disease mechanism (aggregation and structural changes).",
            "judgment": "Yes"
          },
          {
            "step": "3a",
            "description": "No explicit mention of controls or replicates in the provided text.",
            "judgment": "No"
          },
          {
            "step": "3b",
            "description": "Standard techniques (fluorescence, NMR) are broadly accepted in the field.",
            "judgment": "Yes"
          },
          {
            "step": "4b",
            "description": "No OddsPath calculation mentioned. Total benign/pathogenic variant controls not specified in the text.",
            "judgment": "Max PS3_supporting"
          }
        ],
        "evidence_strength": "PS3_supporting"
      }
    },
    {
      "variant": {
        "gene": "SNCA",
        "protein_change": {
          "ref": "S",
          "alt": "N",
          "position": "87"
        },
        "variant_string_id": "SNCA S87N"
      },
      "functional_evidence": {
        "evidence_aim": "Pathogenic",
        "steps": [
          {
            "step": "1",
            "description": "Defined disease mechanism: α-synuclein aggregation is linked to Parkinson's disease (PD).",
            "judgment": "Yes"
          },
          {
            "step": "2",
            "description": "Assays (fluorescence analysis, NMR chemical shift analysis) are relevant to the disease mechanism (aggregation and structural changes).",
            "judgment": "Yes"
          },
          {
            "step": "3a",
            "description": "No explicit mention of controls or replicates in the provided text.",
            "judgment": "No"
          },
          {
            "step": "3b",
            "description": "Standard techniques (fluorescence, NMR) are broadly accepted in the field.",
            "judgment": "Yes"
          },
          {
            "step": "4b",
            "description": "No OddsPath calculation mentioned. Total benign/pathogenic variant controls not specified in the text.",
            "judgment": "Max PS3_supporting"
          }
        ],
        "evidence_strength": "PS3_supporting"
      }
    }
  ]
}